Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Zacks Investment Research

17 Jun 2026, 22:50 UTC · 1h ago

Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims

4 claims · each scored for market impact

What matters in this story

1
Amgen's projected earnings per share (EPS) for the upcoming quarter are $5.55, representing a 7.81% decrease year-over-year. — A significant projected decline in quarterly earnings typically puts downward pressure on a stock price.
-0.40
2
Amgen is currently trading at a Forward P/E ratio of 15.65, which is a discount compared to the industry average of 21.05. — Trading at a discount to industry peers suggests the stock may be undervalued, which is generally positive for investors.
+0.30
3
Amgen's consensus revenue estimate for the upcoming quarter is $9.44 billion, a 2.87% increase compared to the year-ago quarter. — Modest revenue growth is a positive signal, though it is offset by the projected EPS decline.
+0.20
4